As of April 19, 2025, Aeterna Zentaris (AEZS) has a market cap of $17.513 million USD. According to our data, Aeterna Zentaris is ranked No.8609 in global market value.
Year | Market Cap | %Change |
---|---|---|
Oct 10, 2024 | $17.51 M |
2,156.60%
|
Dec 29, 2023 | $0.51 M |
-65.65%
|
Dec 30, 2022 | $1.47 M |
0.21%
|
Dec 31, 2021 | $1.47 M |
-10.66%
|
Dec 31, 2020 | $1.65 M |
114.92%
|
Dec 31, 2019 | $0.77 M |
-4.62%
|
Dec 31, 2018 | $0.80 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
Market Cap | = | AEZS Stock Price | * | AEZS Shares Outstanding |
= | $3.73 | * | 3.06 M | |
= | $17.51 M |